日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease

线粒体酰胺肟还原组分 1 (mARC1) A168T 氨基酸替换在多种慢性肝病小鼠模型中均不能预防 MASH 和纤维化。

Pandovski, Sentibel; Yang, Tiffany; Zhou, Heather; Rosahl, Thomas W; Carballo-Jane, Ester; Talukdar, Saswata; Coyne, Erin S

Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease

线粒体酰胺肟还原组分 1 (mARC1) 的缺失可通过减少多种慢性肝病小鼠模型中的纤维化来阻止疾病进展。

Coyne, Erin S; Nie, Yilin; Lee, Darwin; Pandovski, Sentibel; Yang, Tiffany; Zhou, Heather; Rosahl, Thomas W; Carballo-Jane, Ester; Abdurrachim, Desiree; Zhou, Yongqi; Hendra, Christopher; Ali, Asad Abu Bakar; Meyers, Stacey; Blumenschein, Wendy; Gongol, Brendan; Liu, Yang; Zhou, Yingjiang; Talukdar, Saswata

The extracellular matrix integrates mitochondrial homeostasis

细胞外基质整合线粒体稳态

Hanlin Zhang, C Kimberly Tsui, Gilberto Garcia, Larry K Joe, Haolun Wu, Ayane Maruichi, Wudi Fan, Sentibel Pandovski, Peter H Yoon, Brant M Webster, Jenni Durieux, Phillip A Frankino, Ryo Higuchi-Sanabria, Andrew Dillin